Tag Archives: Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE)

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Healthcare Pathways For People Living With Dementia: World Alzheimer Report 2016 (Alzheimer’s Disease International)

Posted on October 6, 2016 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2016, entitled “Improving healthcare for people living with dementia” reviews evidence on aspects of healthcare for people with dementia and suggests how improvements and efficiency savings can be made. The authors are against over-specialization of … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged 10/66 Dementia Research Group, Access to Palliative Care, ADI’s World Alzheimer Reports, Advance Care Planning (ACP), Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International’s 10/66 Dementia Research Group, Benefits of Case Management, Better Policies for People with Dementia, Canada, Canadian Centre for Family Medicine Family Health Team (CCFM-FHT) Ontario Memory Clinic, Canadian Comfort Care Booklet, Canadian Comfort Care Principles, Canadian Mild Dementia Knowledge Transfer Toolkit, Care Coordination / Case Management Approaches For People With Dementia Living at Home, Care Coordination and Navigation, Case Management for Dementia, Challenges of Living with Dementia, China, Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community (Queensland University of Technology), Community Care, Community Care Services, Community-Based Care, Community-Based Care for People With Dementia, Cost Implications of Dementia Healthcare Pathways, Counter-Factual Service Modelling, Dedicated Care Coordination, Dementia Care in Acute General Hospitals, Dementia Care Pathways, Dementia Healthcare Pathways, Dementia Post-Diagnostic Care and Support, Dementia Research Priorities For Healthcare Sector (WHO Research Prioritization Exercise), Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia: Prevalence and Detection, Early Detection of Alzheimer’s Disease, European Association for Palliative Care White Paper, Global Action Against Dementia, Global Burden of Dementia, Global Context, Global Costs of Dementia, Global Dementia Crisis, Global Dementia Crisis: Adaptations to Services, Global Dementia Crisis: Re-Balancing of Funding For Services, Global Dementia Crisis: Re-Balancing of Services, Global Health, Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Global Outlook, Health Service and Population Research Department: King’s College London, Improving Healthcare For People Living With Dementia: World Alzheimer Report 2016, Improving Outcomes for People Living With Dementia, Indonesia, Integrated and Community-Based Care, Integration of Primary Secondary and Community Care, King’s College London, Living with Dementia, London School of Economics and Political Science (LSE), LSE's Personal Social Services Research Unit (PSSRU), Managing Comorbidity and Complexity, Mexico, Palliative Care, Personal Social Services Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Primary Care, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), PSSRU at London School of Economics and Political Science, Queensland University of Technology Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community, South Africa, South Korea, Switzerland, Systematic Reviews and Meta-Analyses, Task-Sharing, Task-Shifting, Typical Duration of Care Inputs Across the Care Pathway, Typical Intensity / Frequency of Care Inputs Across the Care Pathway, World Alzheimer Report 2016, World Health Organization Mental Health Gap Action Programme (mhGAP) Evidence Based Guidelines | Leave a comment

Dementia Evidence Toolkit Launched (PSSRU at LSE / MODEM / NIHR)

Posted on August 9, 2016 by Dementia and Elderly Care News

Summary The new Dementia Evidence Toolkit has been built on a database of 3,000 journal articles and 700 reviews of research studies. This ambitious and world-leading online resource aims to offer a one-stop “hub” from which to access the latest evidence … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Assistive Technology, Commissioning, Community Care, Delirium, Depression, End of Life Care, Falls, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Guidelines, Hip Fractures, Hypertension, In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Nutrition, Pain, Parkinson's Disease, Patient Information, Person-Centred Care, Personalisation, Quick Insights, Standards, Systematic Reviews, Telecare, Telehealth, UK, Universal Interest | Tagged ADLs/IADLs, Advance Care Planning (ACP), Ageing Population, Alzheimer’s Disease, Care Home Admission Delay, Carer Burden, Carer Outcomes (Financial Burden and More), Carers’ Mental Health, Carers’ Physical Health, Choice in Health and Social Care, Co-Morbidities, Cognition, Cognitive Stimulation Therapy (CST), Community Settings, Consumer Experiences of Health and Social Care, Day Care, Dementia (General / Unspecified), Dementia Evidence Toolkit, Dementia Evidence Toolkit (MODEM): Evidence Database, Dementia Evidence Toolkit (MODEM): Evidence Summaries, Dementia Research, Dementia: What Works?, Depression and Anxiety, Early-Onset Dementia, Economic and Social Research Council (ESRC), Education and Staff Training, ESCR and NIHR’s Improving Dementia Care Initiative, Extra Care Housing, Fronto-Temporal Dementia, Global Leadership, Health and Social Care, Health and Social Care Services, Hospital Inpatient Care, Hospital Outpatient Care, Hospital Use Reduction, Huntingtons, Innovation in Health and Social Care, Instruments Measuring Carer Burden, Lewy Body Dementia, London School of Economics and Political Science (LSE), Long Term Residential Care Without Medically Trained Staff, LSE's Personal Social Services Research Unit (PSSRU), Maintenance Cognitive Stimulation Therapy (CST), Memory Clinics, Mild Cognitive Impairment (MCI), Modelling the Outcome and Cost Impacts of Interventions for Dementia Project (MODEM), MODEM, MODEM (Modelling the Outcome and Cost Impacts of Interventions for Dementia) Project, Museums, Music Therapy, National Institute for Health Research (NIHR), National Institute for Health Research (NIHR)’s Improving Dementia Care Initiative, Nursing Homes, Outcomes, Parkinson’s Dementia, Personal Social Services Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Physical Health, Pick’s Disease, Prevention and/or Management of Co-morbidities, Primary Care, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), PSSRU at LSE, Quality of Life of Carers, Quality Of Life Of Person With Dementia, Satisfaction With Care/services, Service Cost Reductions, Service Use, Specialist Dementia Centre Care / Memory Clinics, Staff Training, Staff Training in Assisted Living Residences (STAR), START: STrAtegies for RelaTives, STrAtegies for RelaTives (START), Supporting People with Dementia and Their Carers in Health and Social Care, Types of Dementia, Vascular Dementia, Workforce Training | Leave a comment

National Dementia Policy: Formation of Dementia Advisory Group (Department of Health / Dementia Challenge)

Posted on December 21, 2014 by Dementia and Elderly Care News

Summary The Department of Health intends to publish a renewed “vision” for strategic direction, with plans up to 2020, on the future of dementia policy in England. It should be ready by early 2015. This will continue and extend existing … Continue reading →

Steps to Unfreeze the Glacial Pace of Dementia Research and Drugs Development (BBC News / Department of Health / Dementia Challenge / World Dementia Council)

Posted on June 19, 2014 by Dementia and Elderly Care News

Summary World Dementia Envoy, Dr Dennis Gillings, has commented on how progress on new research and treatments for dementia has been “achingly slow”. The World Dementia Council, led by the World Dementia Envoy, is meeting today; six months after the … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, BBC News, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Academia-Industry Partnerships, African Agricultural Capital Fund, Araclon, AstraZeneca, BBC Health News, Blackfriars Consensus Statement, Challenge on Dementia (David Cameron), Charitable Funding, Collaborative Projects, Cross-Sector Partnerships, Crowdsource Investment, Data Sharing, Defeat Dementia Campaign, Dementia Challenge, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Time-Bomb, Dementia-Friendly Communities, Dennis Gillings: Former World Dementia Envoy, Diet, Diet and Dementia, Dietary Factors, Dr Etienne Hirsch: INSERM, Dr Linda Elam: Department of Health and Human Services (United States), Dr Neil Buckholtz: National Institute on Aging (NIA) and National Institutes of Health (NIH), Dr Paul Wicks: PatientsLikeMe, Dr Shekhar Saxena: Director of the Department of Mental Health and Substance Abuse at World Health Organization (WHO), Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Dr. Luc Truyen: Johnson&Johnson, Dr. Maria C. Carrillo: Alzheimer’s Association US, Dr. Yoshiki Niimi: Ministry of Health Labour and Welfare (Japan), DY Suharya: Alzheimer's Indonesia, Elisabetta Vaudano: Innovative Medicines Initiative, EU Joint Programme on Neurodegenerative Disease Research (JPND), Former Health Secretary Jeremy Hunt, G7 Global Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Agreements, Gates Global Health Innovative Technology Fund, Genomics, Genomics in the NHS, George Vradenburg: President and Chairman of the Vradenburg Foundation and US Against Alzheimer’s, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Dementia Legacy Event on Finance and Social Investment, Global Dementia Legacy Event Speech (Dr Gillings), Global Digital Platform (for Dementia Research), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Gregory Simon: Polliwogg, GSK, Improving Care for People with Dementia, Incentives and Investment, Incentives for Drug Development, Innovation, Innovative Medicines Initiative (IMI), International Collaborations, International Programmes, IXICO, Janssen Research & Development, John Ryan: European Commission Public Health Directorate, Johnson & Johnson Innovation, Joint Programme on Neurodegenerative Disease Research (JPND), Jon Rouse: Department of Health, KHP/ LSHTM Centre for Global Mental Health: Kings College London, Kings College London, Layered Funding Models, Leadership, Legacies and Charitable Giving, Lifestyle Factors, Lifestyle Risk Factors, London School of Economics, Marc Wortmann: Executive Director of Alzheimer's Disease International (ADI), Market Failure, Market Failure (Dementia Research and Drug Development), Matthew Bishop: Author of Philanthrocapitalism, Medical Research Council (MRC), Medical Research Council's UK Dementias Research Platform (UKDP), MedImmune, Modifiable Risk Factors, Mr. Dirk Pilat: Directorate for Science, Mr. Mark Boleat: City of London, MRC UK Dementias Research Platform (UKDP), Ms Inez Jabalpurwala: Brain Canada Foundation, Ms. Cathrin Petty: JP Morgan, Openness and Collaboration, Orphan Diseases, Orphan Drug Act (United States), Partnership, Partnership and Collaboration, Partnership Working, Patent Box, Patents: Extended Period of Exclusivity, Payment Systems and Incentives, Philanthrocapitalism, Philanthropic Funding, Philanthropy, Policy Innovation, Prevention, Prime Minister’s Dementia Challenge, Professor Andrew Lo: MIT Sloan Professor of Finance, Professor Lefkos Middleton: Imperial College London, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Ronald Petersen: Mayo Alzheimer’s Disease Research Center, Promoting Brain Health (Blackfriars Consensus Statement), Public Health, Public-Private Partnership (PPP), Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Resource and Incentives, Risk Factors, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Entrepreneurs, Social Finance, Social Impact Bonds, Social Impact Investment, Social Investment, Social Media, SomaLogic, Stephen Johnston: Aging2.0 and Generator Ventures, Technology and Industry (OECD) & Technical Advisor to the World Dementia Council, Tom Wright CBE: Age UK, UK Dementias Research Platform, UK Dementias Research Platform (UKDP), UK Presidency of G8 2013, Use of Social Media, World Dementia Council | 1 Comment

World Dementia Council’s First Newsletter (World Dementia Council)

Posted on June 1, 2014 by Dementia and Elderly Care News

Summary The World Dementia Envoy, Dr Dennis Gillings, has published the first edition of the World Dementia Council Newsletter. This is available in six languages. Full Text Link Reference First World Dementia Council Newsletter. London: Department of Health / Dementia … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Department of Health, Diagnosis, End of Life Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged Academia-Industry Partnerships, Alzheimer’s Study Group, Beatrice Lorenzin: Italian Health Minister, Bill & Melinda Gates Foundation, Canadian Institute of Health Research (Institute of Aging), Challenge on Dementia (David Cameron), Chief Medical Officer: Professor Dame Sally Davies, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia Directory (ADI), Dementia Innovation, Dementia Research, Dennis Gillings: Former World Dementia Envoy, Diageo plc, Disease-Modifying Therapies for Dementia, Dr Kiyoshi Kurokawa: Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), European Commission, Franz Humer: Chairman of Diageo plc, G8 Dementia Summit, G8 Dementia Summit Agreements, G8 Dementia Summit Declaration, GE Healthcare, George Vradenburg: President and Chairman of the Vradenburg Foundation and US Against Alzheimer’s, German Centre for Neurodegenerative Diseases, Global Action Against Dementia, Global Compendium for Dementia Efforts (the Digest), Global Context, Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Government Research Funding, Group of 7 (G7), Health Nutrition and Population at the World Bank, ICM Brain and Spine Institute (Paris), International Collaborations, International Programmes, Italian Health Ministry, Japan, Johnson & Johnson, Knowledge Translation, Leadership, London School of Economics, Mayo Alzheimer’s Disease Research Center, National Graduate Institute for Policy Studies, National Institute of Health’s Global Alzheimer’s Research Summit (United States), OECD Deputy Secretary-General, Office for Economic Co-operation and Development (OECD), Organisation for Economic Co-operation and Development (OECD), Partnership, Partnership and Collaboration, Partnership Working, Paul Stoffels: Worldwide Chairman of Johnson & Johnson, Prime Minister’s Dementia Challenge, Professor Dame Sally Davies, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Pierluigi Nicotera: Scientific Director and Chairman of the Executive Board at the German Centre for Neurodegenerative Diseases, Professor Ronald Petersen: Mayo Alzheimer’s Disease Research Center, Quintiles, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Sir William Castell: Chairman of the Wellcome Trust, Tackling Barriers to Innovation, Tim Evans: Director for Health Nutrition and Population at the World Bank, UK Government Digest: Global Compendium on Dementia-Related Work, US Against Alzheimer’s, USAgainstAlzheimer’s (USA2), Vradenburg Foundation, Wellcome Trust, WHO Global Advisory Committee on Health Research (ACHR), Who's Who Dementia Directory (ADI), WHO: World Health Organization, World Dementia Council Members, World Dementia Council Newsletter, World Dementia Envoy, Yves Leterme: Former Deputy Secretary-General of the OECD | Leave a comment

World Dementia Council Underway (Department of Health / Dementia Challenge / World Dementia Council)

Posted on May 4, 2014 by Dementia and Elderly Care News

Summary Initial members of the World Dementia Council have been announced, with indications of more members to follow. The council is led by the Dr Dennis Gillings: the World Dementia Envoy. The World Dementia Council has the aim of promoting … Continue reading →

Posted in Charitable Bodies, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged Academia-Industry Partnerships, Alzheimer’s Study Group, Bill & Melinda Gates Foundation, Canadian Institute of Health Research (Institute of Aging), Challenge on Dementia (David Cameron), Chief Medical Officer: Professor Dame Sally Davies, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia Innovation, Dementia Research, Dennis Gillings: Former World Dementia Envoy, Diageo plc, Disease-Modifying Therapies for Dementia, Dr Kiyoshi Kurokawa: Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Franz Humer: Chairman of Diageo plc, G8 Dementia Summit, G8 Dementia Summit Agreements, G8 Dementia Summit Declaration, GE Healthcare, George Vradenburg: President and Chairman of the Vradenburg Foundation and US Against Alzheimer’s, German Centre for Neurodegenerative Diseases, Global Action Against Dementia, Global Context, Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Government Research Funding, Group of 7 (G7), Health Nutrition and Population at the World Bank, International Collaborations, International Programmes, Japan, Johnson & Johnson, Knowledge Translation, Leadership, London School of Economics, Mayo Alzheimer’s Disease Research Center, National Graduate Institute for Policy Studies, National Institute of Health’s Global Alzheimer’s Research Summit (United States), OECD Deputy Secretary-General, Organisation for Economic Co-operation and Development (OECD), Partnership, Partnership and Collaboration, Partnership Working, Paul Stoffels: Worldwide Chairman of Johnson & Johnson, Prime Minister’s Dementia Challenge, Professor Dame Sally Davies, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Pierluigi Nicotera: Scientific Director and Chairman of the Executive Board at the German Centre for Neurodegenerative Diseases, Professor Ronald Petersen: Mayo Alzheimer’s Disease Research Center, Quintiles, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Sir William Castell: Chairman of the Wellcome Trust, Tackling Barriers to Innovation, Tim Evans: Director for Health Nutrition and Population at the World Bank, US Against Alzheimer’s, USAgainstAlzheimer’s (USA2), Vradenburg Foundation, Wellcome Trust, WHO Global Advisory Committee on Health Research (ACHR), World Bank, World Dementia Council, World Dementia Envoy, Yves Leterme: Former Deputy Secretary-General of the OECD | 1 Comment

Tag Archives: Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE)

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Healthcare Pathways For People Living With Dementia: World Alzheimer Report 2016 (Alzheimer’s Disease International)

Dementia Evidence Toolkit Launched (PSSRU at LSE / MODEM / NIHR)

National Dementia Policy: Formation of Dementia Advisory Group (Department of Health / Dementia Challenge)

Steps to Unfreeze the Glacial Pace of Dementia Research and Drugs Development (BBC News / Department of Health / Dementia Challenge / World Dementia Council)

World Dementia Council’s First Newsletter (World Dementia Council)

World Dementia Council Underway (Department of Health / Dementia Challenge / World Dementia Council)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites